SAVA
NASDAQ · Pharmaceuticals
Cassava Sciences Inc
$0.45
+0.00 (+0.38%)
Open$0.46
Previous Close$0.45
Day High$0.47
Day Low$0.43
52W High$3.45
52W Low$0.45
Volume—
Avg Volume436.6K
Market Cap114.97M
P/E Ratio—
EPS$-2.20
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 22.84M | 20.47M | 21.96M |
| Net Income | 4.14M | 5.17M | 4.25M |
| Profit Margin | 18.1% | 25.2% | 19.3% |
| EBITDA | 7.09M | 5.98M | 7.27M |
| Free Cash Flow | 3.09M | 2.63M | 3.14M |
| Rev Growth | -6.9% | +1.2% | +18.5% |
| Debt/Equity | 1.35 | 1.36 | 1.39 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,403.15 | +3.63% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.29 | +1.84% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $147.81 | +0.74% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.47 | +0.27% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $82.35 | +3.72% | 12.8 | 33.59B |